Logo image of ESTA

ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis

NASDAQ:ESTA - Nasdaq - VGG312491084 - Common Stock - Currency: USD

33.43  -1.6 (-4.57%)

After market: 33 -0.43 (-1.29%)

Fundamental Rating

2

Taking everything into account, ESTA scores 2 out of 10 in our fundamental rating. ESTA was compared to 190 industry peers in the Health Care Equipment & Supplies industry. ESTA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ESTA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ESTA has reported negative net income.
ESTA had a negative operating cash flow in the past year.
ESTA had negative earnings in each of the past 5 years.
In the past 5 years ESTA always reported negative operating cash flow.
ESTA Yearly Net Income VS EBIT VS OCF VS FCFESTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -24.98%, ESTA perfoms like the industry average, outperforming 48.40% of the companies in the same industry.
ESTA's Return On Equity of -215.86% is on the low side compared to the rest of the industry. ESTA is outperformed by 78.72% of its industry peers.
Industry RankSector Rank
ROA -24.98%
ROE -215.86%
ROIC N/A
ROA(3y)-31.44%
ROA(5y)-30.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESTA Yearly ROA, ROE, ROICESTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400 600 800

1.3 Margins

ESTA's Gross Margin of 65.08% is fine compared to the rest of the industry. ESTA outperforms 67.55% of its industry peers.
In the last couple of years the Gross Margin of ESTA has grown nicely.
The Profit Margin and Operating Margin are not available for ESTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.48%
GM growth 5Y1.89%
ESTA Yearly Profit, Operating, Gross MarginsESTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ESTA has more shares outstanding than it did 1 year ago.
ESTA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ESTA has been reduced compared to a year ago.
ESTA Yearly Shares OutstandingESTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ESTA Yearly Total Debt VS Total AssetsESTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

ESTA has an Altman-Z score of 0.70. This is a bad value and indicates that ESTA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ESTA (0.70) is comparable to the rest of the industry.
ESTA has a Debt/Equity ratio of 5.94. This is a high value indicating a heavy dependency on external financing.
ESTA's Debt to Equity ratio of 5.94 is on the low side compared to the rest of the industry. ESTA is outperformed by 89.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.94
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACCN/A
WACC8.38%
ESTA Yearly LT Debt VS Equity VS FCFESTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

A Current Ratio of 3.62 indicates that ESTA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.62, ESTA is in the better half of the industry, outperforming 64.89% of the companies in the same industry.
A Quick Ratio of 2.29 indicates that ESTA has no problem at all paying its short term obligations.
ESTA's Quick ratio of 2.29 is in line compared to the rest of the industry. ESTA outperforms 55.32% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 2.29
ESTA Yearly Current Assets VS Current LiabilitesESTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.86% over the past year.
Looking at the last year, ESTA shows a very negative growth in Revenue. The Revenue has decreased by -13.71% in the last year.
The Revenue has been growing by 21.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.32%
Revenue 1Y (TTM)-13.71%
Revenue growth 3Y24.93%
Revenue growth 5Y21.96%
Sales Q2Q%4.47%

3.2 Future

The Earnings Per Share is expected to grow by 20.18% on average over the next years. This is a very strong growth
ESTA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.79% yearly.
EPS Next Y17.8%
EPS Next 2Y17.07%
EPS Next 3Y17.85%
EPS Next 5Y20.18%
Revenue Next Year0.75%
Revenue Next 2Y11.82%
Revenue Next 3Y15.9%
Revenue Next 5Y25.79%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ESTA Yearly Revenue VS EstimatesESTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 200M 400M 600M
ESTA Yearly EPS VS EstimatesESTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 1 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ESTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ESTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESTA Price Earnings VS Forward Price EarningsESTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESTA Per share dataESTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

ESTA's earnings are expected to grow with 17.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.07%
EPS Next 3Y17.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ESTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ESTABLISHMENT LABS HOLDINGS

NASDAQ:ESTA (2/21/2025, 8:16:09 PM)

After market: 33 -0.43 (-1.29%)

33.43

-1.6 (-4.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners106.27%
Inst Owner Change-94.73%
Ins Owners6.84%
Ins Owner Change0.23%
Market Cap936.04M
Analysts84.62
Price Target61.2 (83.07%)
Short Float %20.22%
Short Ratio9.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.39%
Min EPS beat(2)-18.72%
Max EPS beat(2)5.95%
EPS beat(4)3
Avg EPS beat(4)4.29%
Min EPS beat(4)-18.72%
Max EPS beat(4)15%
EPS beat(8)6
Avg EPS beat(8)5.29%
EPS beat(12)7
Avg EPS beat(12)-25.58%
EPS beat(16)9
Avg EPS beat(16)-22.19%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)0.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.63%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)1.21%
Revenue beat(8)4
Avg Revenue beat(8)-1.14%
Revenue beat(12)7
Avg Revenue beat(12)0.25%
Revenue beat(16)11
Avg Revenue beat(16)2.03%
PT rev (1m)-0.47%
PT rev (3m)-0.47%
EPS NQ rev (1m)0.5%
EPS NQ rev (3m)0.5%
EPS NY rev (1m)0.14%
EPS NY rev (3m)-3.05%
Revenue NQ rev (1m)-3.84%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-2.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.12
P/FCF N/A
P/OCF N/A
P/B 28.62
P/tB 41.67
EV/EBITDA N/A
EPS(TTM)-2.58
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-2.3
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS5.47
BVpS1.17
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.98%
ROE -215.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.08%
FCFM N/A
ROA(3y)-31.44%
ROA(5y)-30.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.48%
GM growth 5Y1.89%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 5.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 311.7%
Cap/Sales 12.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 2.29
Altman-Z 0.7
F-Score3
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)551.89%
Cap/Depr(5y)394.77%
Cap/Sales(3y)13.79%
Cap/Sales(5y)10.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.32%
EPS Next Y17.8%
EPS Next 2Y17.07%
EPS Next 3Y17.85%
EPS Next 5Y20.18%
Revenue 1Y (TTM)-13.71%
Revenue growth 3Y24.93%
Revenue growth 5Y21.96%
Sales Q2Q%4.47%
Revenue Next Year0.75%
Revenue Next 2Y11.82%
Revenue Next 3Y15.9%
Revenue Next 5Y25.79%
EBIT growth 1Y4.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.13%
EBIT Next 3Y32.04%
EBIT Next 5Y32.27%
FCF growth 1Y12.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.11%
OCF growth 3YN/A
OCF growth 5YN/A